David M. Aboulafia

7.6k total citations
174 papers, 4.3k citations indexed

About

David M. Aboulafia is a scholar working on Oncology, Pathology and Forensic Medicine and Epidemiology. According to data from OpenAlex, David M. Aboulafia has authored 174 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Oncology, 57 papers in Pathology and Forensic Medicine and 40 papers in Epidemiology. Recurrent topics in David M. Aboulafia's work include Viral-associated cancers and disorders (81 papers), Lymphoma Diagnosis and Treatment (55 papers) and Chronic Lymphocytic Leukemia Research (28 papers). David M. Aboulafia is often cited by papers focused on Viral-associated cancers and disorders (81 papers), Lymphoma Diagnosis and Treatment (55 papers) and Chronic Lymphocytic Leukemia Research (28 papers). David M. Aboulafia collaborates with scholars based in United States, United Kingdom and Canada. David M. Aboulafia's co-authors include Bruce J. Dezube, Jeannette Y. Lee, Ronald T. Mitsuyasu, Albert J. Aboulafia, Liron Pantanowitz, William Hage, Denise Bundow, Rom S. Leidner, Prakash Vishnu and P Rubinstein and has published in prestigious journals such as New England Journal of Medicine, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

David M. Aboulafia

167 papers receiving 4.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David M. Aboulafia 2.3k 1.2k 1.1k 859 598 174 4.3k
Emanuela Vaccher 3.5k 1.5× 2.2k 1.8× 1.1k 1.1× 440 0.5× 948 1.6× 177 5.0k
Jean‐Pierre Clauvel 1.3k 0.6× 807 0.6× 950 0.9× 415 0.5× 794 1.3× 63 4.0k
A Levine 1.3k 0.6× 705 0.6× 849 0.8× 486 0.6× 417 0.7× 45 2.7k
Thomas S. Uldrick 3.2k 1.4× 1.4k 1.1× 1.3k 1.2× 232 0.3× 753 1.3× 123 4.3k
Patrice Morel 761 0.3× 933 0.7× 1.3k 1.2× 383 0.4× 483 0.8× 123 3.3k
Andrew E. Grulich 2.8k 1.2× 922 0.7× 1.6k 1.5× 980 1.1× 481 0.8× 56 4.9k
Ulrike Pötschger 1.2k 0.5× 662 0.5× 529 0.5× 1.2k 1.4× 1.2k 2.0× 99 5.3k
Timothy R. Coté 1.2k 0.5× 704 0.6× 767 0.7× 1.1k 1.2× 312 0.5× 51 3.9k
Sam M. Mbulaiteye 2.4k 1.0× 1.1k 0.9× 1.3k 1.2× 381 0.4× 763 1.3× 113 3.6k
Dan Knowles 3.1k 1.4× 2.1k 1.7× 1.2k 1.1× 243 0.3× 669 1.1× 64 6.0k

Countries citing papers authored by David M. Aboulafia

Since Specialization
Citations

This map shows the geographic impact of David M. Aboulafia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David M. Aboulafia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David M. Aboulafia more than expected).

Fields of papers citing papers by David M. Aboulafia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David M. Aboulafia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David M. Aboulafia. The network helps show where David M. Aboulafia may publish in the future.

Co-authorship network of co-authors of David M. Aboulafia

This figure shows the co-authorship network connecting the top 25 collaborators of David M. Aboulafia. A scholar is included among the top collaborators of David M. Aboulafia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David M. Aboulafia. David M. Aboulafia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bennett, Charles L., Antonio J. Trujillo, Kenneth R. Carson, et al.. (2024). Congressional Investigation of RevAssist-Linked and General Pricing Strategies for Lenalidomide. JCO Oncology Practice. 20(8). 1021–1026. 2 indexed citations
2.
3.
4.
Haigentz, Missak, Jeannette Y. Lee, Elizabeth Y. Chiao, et al.. (2023). Phase I Trial of the Multi-kinase Inhibitor Cabozantinib, a CYP3A4 Substrate, plus CYP3A4-Interacting Antiretroviral Therapy in People Living with HIV and Cancer (AMC-087). Clinical Cancer Research. 29(24). 5038–5046. 3 indexed citations
5.
Reid, Erin, Kelly A. Shimabukuro, Page C. Moore, et al.. (2022). AMC-070: Lenalidomide Is Safe and Effective in HIV-Associated Kaposi Sarcoma. Clinical Cancer Research. 28(12). 2646–2656. 12 indexed citations
6.
Ramos, Juan Carlos, Joseph A. Sparano, Amy Chadburn, et al.. (2020). Impact of Myc in HIV-associated non-Hodgkin lymphomas treated with EPOCH and outcomes with vorinostat (AMC-075 trial). Blood. 136(11). 1284–1297. 36 indexed citations
7.
Reid, Erin, Shelly Lensing, Dirk P. Dittmer, et al.. (2019). Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma. Clinical Cancer Research. 26(3). 558–565. 14 indexed citations
8.
Reid, Erin, David J. Looney, Frank Maldarelli, et al.. (2018). Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas. Blood Advances. 2(24). 3618–3626. 9 indexed citations
9.
10.
11.
Jacobs, Benjamin M., Nancy Neil, & David M. Aboulafia. (2005). Retrospective Analysis of Suspending HAART in Selected Patients with Controlled HIV Replication. AIDS Patient Care and STDs. 19(7). 429–438. 2 indexed citations
12.
Leidner, Rom S. & David M. Aboulafia. (2005). Recrudescent Kaposi's Sarcoma After Initiation of HAART: A Manifestation of Immune Reconstitution Syndrome. AIDS Patient Care and STDs. 19(10). 849–858. 9 indexed citations
13.
Leidner, Rom S. & David M. Aboulafia. (2005). Recrudescent Kaposi's Sarcoma After Initiation of HAART: A Manifestation of Immune Reconstitution Syndrome. AIDS Patient Care and STDs. 19(10). 635–644. 120 indexed citations
14.
Aboulafia, David M., Liron Pantanowitz, & Bruce J. Dezube. (2004). AIDS-related non-Hodgkin lymphoma: still a problem in the era of HAART.. PubMed. 14(11). 605–17. 32 indexed citations
15.
16.
Aboulafia, David M. & Lynne P. Taylor. (2002). Vacuolar Myelopathy and Vacuolar Cerebellar Leukoencephalopathy: A Late Complication of AIDS After Highly Active Antiretroviral Therapy-Induced Immune Reconstitution. AIDS Patient Care and STDs. 16(12). 579–584. 12 indexed citations
17.
Aboulafia, David M., et al.. (2000). Simvastatin-Induced Rhabdomyolysis in an HIV-Infected Patient with Coronary Artery Disease. AIDS Patient Care and STDs. 14(1). 13–18. 29 indexed citations
18.
Aboulafia, David M., et al.. (1997). Efficacy of Total Parenteral Nutrition in a Series of End-Stage AIDS Patients: A Case-Control Study. AIDS Patient Care and STDs. 11(5). 323–329. 2 indexed citations
19.
Aboulafia, David M., et al.. (1993). Human T Cell Leukemia Virus (HTLV-I/II) Serodiagnostic Testing: Disparate Results among a Cohort of Intravenous Drug Users. AIDS Research and Human Retroviruses. 9(10). 1043–1050. 5 indexed citations
20.
Aboulafia, David M., Ronald T. Mitsuyasu, & Dennis J. Slamon. (1991). Human T-Cell Leukemia Virus Infection in Non-Intravenous Drug Using HIV Seropositive Men in Los Angeles. AIDS Research and Human Retroviruses. 7(3). 333–336. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuela Vaccher Breakdown of academic impact, for papers by Jean‐Pierre Clauvel Breakdown of academic impact, for papers by A Levine Breakdown of academic impact, for papers by Thomas S. Uldrick Breakdown of academic impact, for papers by Patrice Morel Breakdown of academic impact, for papers by Andrew E. Grulich Breakdown of academic impact, for papers by Ulrike Pötschger Breakdown of academic impact, for papers by Timothy R. Coté Breakdown of academic impact, for papers by Sam M. Mbulaiteye Breakdown of academic impact, for papers by Dan Knowles
Rankless by CCL
2026